Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes (Q36560412)
Jump to navigation
Jump to search
scientific article published on 18 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes |
scientific article published on 18 October 2012 |
Statements
1 reference
Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes (English)
1 reference
Kohei Kaku
1 reference
Takahiro Araki
1 reference
Ryoji Yoshinaka
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference